Standard BioTools Inc. (LAB) vs Treace Medical Concepts, Inc. (TMCI)
- Standard BioTools Inc. LAB 0.63 −4.55%
- Treace Medical Concepts, Inc. TMCI 3.87 −6.07%
Standard BioTools Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. Standard BioTools Inc. and Treace Medical Concepts, Inc. are of similar size ($267.9M and $258.5M). Treace Medical Concepts, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 2.9×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against −3.95%. Standard BioTools Inc. has the higher net margin (100.4% vs −29.0%) and the lower return on invested capital (−93.9% vs −43.0%). Across the 18 metrics below, Standard BioTools Inc. leads on 10 and Treace Medical Concepts, Inc. on 8.
Valuation
Profitability
| Metric | LAB | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.49% | 79.45% | 56.01% |
| Operating margin | (112.85%) | (26.17%) | (15.03%) |
| Net margin | 100.37% | (28.99%) | (20.40%) |
| Free cash flow margin | (97.61%) | (12.20%) | (7.24%) |
| Return on equity | 17.61% | (71.99%) | (15.32%) |
| Return on assets | 14.34% | (30.72%) | (19.72%) |
| Return on invested capital | (93.89%) | (42.96%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack